Indeed, thelapatinib-induced activation of AMPK and the consequent inhibitory effects on protein synthesis andde novo fatty acid biogenesis are lethal to HER2 gene-amplifiedbreast carcinoma cells that are “addicted” to glycolysis [92, 93]. Here, ERBB2 is linked to carcinoma.